The scientific rationale behind each ingredient is sound, though the resistant starch dose falls below what clinical studies used, and the overall evidence base is limited compared to pharmaceutical GLP-1 agonists
By early 2025, nearly 25% of diabetes patients had started a GLP1 therapy, up from just 3% four years ago
Food and Drug Administration prescribing information for semaglutide American Diabetes Association Standards of Care What Happens If You Increase the Dose Too Early
Flatter Me Fiber GLP1 Booster Now available with a boost of natural energy from green tea!* 10g of Clinically Backed Prebiotic Fiber formulated to double GLP-1 levels, curb cravings, and promote regularity. Clinically Tested Ingredients Clinically tested fiber to increase GLP-1 levels in just one use. Supercharged with Flatter Me enzymes blend to debloat fast and support digestion* Natural energy from green tea extract* Subscribe & Save Extra 20% off every order Free samples & earn loyalty points Ships monthly
It says limited prospective studies directly compare antibiotic efficacy in semaglutide-treated versus untreated populations, and that most safety data come from case reports and pharmacokinetic modeling
Caption: Picture 4